Literature DB >> 32129252

Spinocerebellar Ataxias in India: Three‑year Molecular Data from a Central Reference Laboratory.

Aparna Amarendra Bhanushali1, Radhakrishnan Venkatesan1, Bibhu R Das1.   

Abstract

INTRODUCTION: There is a great deal of heterogeneity, both phenotypically and genotypically among the autosomal dominant cerebellar ataxias (ADCA). Their prevalence also varies in different populations. Trinucleotide repeat expansions (CTG/CAG) have been shown predominantly to cause a number of ADCAs. AIM: The present study describes the frequency of spinocerebellar ataxias (SCA) and the CAG repeat sizes among the different regions of India. SETTINGS AND
DESIGN: Molecular data from our central reference laboratory were retrospectively analyzed for SCAs 1, 2, 3, 6, 7, 10, 12, 17 and DRPLA. Correlation between age at diagnosis and the CAG repeats of the expanded and the normal alleles were tested with the Spearman correlation test.
RESULTS: The presence of SCAs vary according to geographical regions and ethnicities; SCA 12 was detected with the highest frequency (229/901), but was restricted to a specific ethnic population, followed by SCA 2 with a positivity of 12% (101/845). SCA 3 previously known as Machado-Joseph Disease had a prevalence of 4.05% (32/789), whereas SCA 1 was diagnosed in 30/773 (3.88%). No positivity was seen for SCA 10 from the 103 samples tested and for SCA 17 from the 131 samples tested either as a part of an extended panel or stand-alone.
CONCLUSION: In this report, we are able to expand the portrait of SCAs in India by presenting the largest ever molecular data from a central reference laboratory.

Entities:  

Keywords:  Autosomal dominant; India; fragment analysis; molecular diagnosis; spinocerebellar ataxias

Mesh:

Substances:

Year:  2020        PMID: 32129252     DOI: 10.4103/0028-3886.279666

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  2 in total

1.  Spinocerebellar Ataxia 12 Patients have better Quality of Life than Spinocerebellar Ataxia 1 and 2.

Authors:  Surekha Dabla; Divyani Garg; Rajeev Aggarwal; Nand Kumar; Mohammad Faruq; Roopa Rajan; Garima Shukla; Vinay Goyal; Ravindra Mohan Pandey; Achal Kumar Srivastava; Surekha Dabla; Divyani Garg; Garima Shukla
Journal:  Ann Indian Acad Neurol       Date:  2022-04-06       Impact factor: 1.714

2.  DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder.

Authors:  Aiysha Chaudhry; Alkyoni Anthanasiou-Fragkouli; Henry Houlden
Journal:  J Neurol       Date:  2020-10-26       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.